RNF5 inhibitor inh-02


CAS No. : 324579-65-9

324579-65-9
Price and Availability of CAS No. : 324579-65-9
Size Price Stock
5mg $230 In-stock
10mg $400 In-stock
25mg $850 In-stock
50mg $1450 In-stock
100mg $2500 In-stock
200 mg Get quote
500 mg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-123967
M.Wt: 384.50
Formula: C23H20N4S
Purity: >98 %
Solubility: DMSO : 83.33 mg/mL (ultrasonic;warming;heat to 60°C)
Introduction of 324579-65-9 :

RNF5 inhibitor inh-02 is a potent inhibitor of E3 ubiquitin ligase RNF5/RMA1. RNF5 inhibitor inh-02 rescues F508del-CFTR function in F508del-CFTR-expressing immortalized cells (CFBE41o⁻, EC50 = 2.6 μM; FRT, EC 50 = 2.2 μM). RNF5 inhibitor inh-02 increases LC3IIB expression and autophagic vacuole number via reducing ATG4B ubiquitylation and promotes cell motility. RNF5 inhibitor inh-02 can be used for the study of cystic fibrosis[1]. In Vitro:RNF5 inhibitor inh-02 (2-10 μM, 24 h) significantly reduces F508del-CFTR ubiquitylation and rescues F508del-CFTR activity (EC50 = 2.6 μM) in CFBE41o- cells stably expressing F508del-CFTR and HS-YFP[1].
RNF5 inhibitor inh-02 (1-10 μM, 24 h) dose-dependently rescues F508del-CFTR activity in F508del-CFTR/HS-YFP-expressing FRT cells with an EC50 of 2.2 μM, and increases CFTR-dependent transepithelial conductance[1].
RNF5 inhibitor inh-02 (5 μM, 24 h) significantly increases CFTR-mediated transepithelial conductance, equivalent short-circuit current and chloride secretion in primary bronchial epithelial cells[1].
RNF5 inhibitor inh-02 (5 μM, 24 h) reduces ATG4B ubiquitylation, increases LC3IIB expression and autophagic vacuole number in CFBE41o- cells[1].
RNF5 inhibitor inh-02 (5 μM, 24 h) promotes cell migration and accelerates scratch gap filling in CFBE41o- cells[1].

Your information is safe with us.